Physician

Nighat Sarwar, M.D.

According to 2025 Medicare claims, Nighat Sarwar, M.D. (NPI: 1003809989) practices neurology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is NIGHAT SARWAR, M.D. INC. (NPI: 1417153362; TIN: 260245982) and primary practice location at 93720-9998. Sarwar is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Sarwar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 584 traditional Medicare patients, billed 140,952 HCPCS/CPT codes, and received $2,560,355 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,309 prescription claims across 409 beneficiaries totaling $2,558,287 in drug costs, led by Kesimpta Pen (Ofatumumab). 2020 DME data shows 12 claims. Open Payments data shows 268 records totaling $12,126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $321,062 and ending at $2,560,355. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $20,115 and ending at $4,558.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	445	17,860	$321,062
2016	384	3,084	$105,831
2017	1,078	118,526	$1,748,110
2018	1,442	261,668	$4,279,468
2019	1,143	191,262	$4,112,062
2020	1,023	107,458	$2,370,901
2021	468	20,948	$965,189
2022	659	38,125	$1,667,456
2023	656	70,342	$2,123,812
2024	584	140,952	$2,560,355

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	300	3,351	$1,708,264
2016	291	3,246	$1,794,934
2017	275	2,907	$1,818,250
2018	269	2,977	$2,555,711
2019	263	2,910	$2,627,316
2020	312	3,275	$2,275,584
2021	340	3,126	$2,212,553
2022	422	3,189	$2,136,955
2023	447	3,368	$2,409,658
2024	409	3,309	$2,558,287

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$433
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	114	114	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	366	705	$85
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	58	252	$45
J0897	Injection, denosumab, 1 mg	65	6,720	$20
96372	Injection of drug or substance under skin or into muscle	82	141	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kesimpta Pen	Ofatumumab	25	900	$296,496
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	13	390	$290,035
Vumerity	Diroximel Fumarate	26	780	$215,562
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	11	330	$206,584
Nuplazid	Pimavanserin Tartrate	30	1,140	$192,810

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	268	$12,126	Biogen, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nighat Sarwar, M.D.?

Tedicare shows public-source Medicare data for Nighat Sarwar, M.D. (NPI 1003809989), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nighat Sarwar, M.D. have ACO affiliation data?

Nighat Sarwar, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Nighat Sarwar, M.D.?

Nighat Sarwar, M.D. is linked to NIGHAT SARWAR, M.D. INC. (billing NPI 1417153362) in the available physician profile data.

Does Nighat Sarwar, M.D. have Open Payments data?

Nighat Sarwar, M.D. has 268 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.